As efficient Cas9 and single-guide RNA transfers are crucial for successful genome editing, Cas9 with single-guide RNA complex (Cas9 ribonucleoprotein (RNP) complex)-based editing and established Cas9 expression plasmid-based editing were employed to estimate efficient Cas9 delivery in GBM cells. This evidence concerns the gene RNPC3 and glioblastoma.